Flu Vaccine Study in Neuromuscular Patients 2011
Comparison of the Immunogenicity of Intramuscular Versus Subcutaneous Administration of Trivalent Inactivated Influenza Vaccine in Individuals With Neuromuscular Diseases
Sponsor: Children's Hospital Medical Center, Cincinnati
Listed as NCT01422200, this PHASE4 trial focuses on Congenital Muscular Dystrophy and Duchenne Muscular Dystrophy and remains completed. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed · Phase: NA → PHASE4
-
Jan 2017 — Nov 2020 [monthly]
Unknown Status NA
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.